A tibial tuberosity advancement implant and method includes a spacer body made of biocompatible, biodegradable material and having a main section with at least one bony growth orifice therethrough and a proximal slot and at least one fin extending from the main section by at least one connector. A metal clip is slideable into the proximal slot of the spacer body main section and includes spaced screw holes for securing the spacer body to the advanced tibial tuberosity and the tibia when the implant is placed in the space between the advanced tibial tuberosity and the tibia.
|
1. A tibial tuberosity advancement implant molded from a biodegradable material and comprising:
a clip;
a main body section including a proximal face adapted for engagement with the clip;
distal spaced cuttable fins extending from the main body section; and
bony growth orifices through the main body section.
11. A tibial tuberosity advancement implant comprising:
a spacer body with a top surface, a bottom surface, and sides surfaces and molded from a biocompatible, biodegradable material and including:
a main section including at least one bony growth orifice therethrough between a proximal face and a distal face, and
fins extending from the main section distal face;
a clip engageable with the main section proximate the proximal face thereof including spaced screw holes for securing the spacer body to an advanced tibial tuberosity and the tibia; and
the fins angled inwardly resulting in a spacer body with the bottom surface shorter than the top surface.
5. The implant of
6. The implant of
7. The implant of
8. The implant of
9. The implant of
10. The implant of
13. The implant of
14. The implant of
16. The implant of
19. The implant of
|
|||||||||||||||||||||||||||||
This application is a divisional of U.S. patent application Ser. No. 13/559,103 filed Jul. 26, 2012, which hereby claims the benefit of and priority thereto under 35 U.S.C. §§119, 120, 363, 365, and 37 C.F.R. §1.55 and §1.78, and which is incorporated herein by reference.
The invention relates to tibial tuberosity advancement procedures in canines.
During the tibial tuberosity advancement procedures in canines, the tibia is cut just behind the tibial tuberosity and the tibial tuberosity is advanced to achieve a perpendicular relationship between the tibial plateau slope and the patella tendon. A titanium or stainless steel implant (also called a cage or spacer) is placed between the advanced tibial tuberosity and the tibia and a plate is used to secure the tibial tuberosity to the tibia.
Over time, bony growth forms in and around the spacer. In the case of an infection or other problem, it can be very difficult to remove the spacer. As many as one in ten tibial tuberosity advancement procedures result in infection or rejection of the spacer implant.
Biocompatible and biodegradable materials are known for use in implants but an implant made of a plastic biodegradable material and designed like prior art metal implants may not be strong enough to maintain the tibial tuberosity in the advanced state as the canine recovers and becomes active. Injection molding limitations also prevent manufacturing a plastic implant designed like the prior art metal tibial tuberosity implant.
In one or more aspects of a preferred embodiment of the invention, a trimable tibial tuberosity advancement implant is molded using a biocompatible, biodegradable material so that in case of infection or the like only the metal clip portion of the implant need be removed (using, for example, minimal invasive surgery techniques). And yet, the implant spacer body is structurally sound until decomposition and bony ingrowth occurs between the advanced tibial tuberosity and the tibia.
Featured is a tibial tuberosity advancement implant comprising a spacer body made of biocompatible, biodegradable material. A main section has at least one bony growth orifice therethrough and also a proximal slot. At least one fin extends from the main section by at least one connector. A clip is slideable into the proximal slot of the main section and includes spaced screw holes for securing the spacer body to the advanced tibial tuberosity and the tibia when the spacer body is implanted.
The clip is usually made of stainless steel or titanium. It preferably includes spaced ears each having a screw hole and upper and lower spaced spring arms interconnecting the spaced ears. Each spring arm then includes an outwardly curved portion including a central cut out and the spacer body main section slot includes spaced upper and lower tabs each received in a cut out of the clip.
The typical biocompatible, biodegradable material used includes polyglycolic acid and/or polylactic acid. Preferably, the spacer body main section includes at lease two spaced bony growth orifices, the spacer body main section has an isosceles trapezoid cross sectional shape, the fins are angled inwardly rendering the top of the implant longer and wider than the bottom and there is a top and a bottom cuttable connector for each fin to customize the length of the implant.
One example of a tibial tuberosity advancement implant in accordance with the invention includes a spacer body made of biocompatible, biodegradable material and including a main section having an isosceles trapezoid cross sectional shape with at least one bony growth orifice therethrough and a proximal slot. Inwardly angled fins extend from the main section rendering the top of the implant longer than the bottom. A clip is slideable into the proximal slot of the main section and includes spaced screw holes for securing the spacer body to the advanced tibial tuberosity and the tibia.
Another tibial tuberosity advancement implant made of biodegradable material includes a proximal face, a slot behind the proximal face for a metal clip, distal spaced cuttable fins, and bony growth orifices in a main body section between the proximal face and the distal fins. Typically, the implant is longer and wider at the top than at the bottom and the body section is configured as an approximation of a concrete block.
This invention also features a method comprising advancing the tibial tuberosity of a canine, implanting a biodegradable spacer to retain the tibial tuberosity in an advanced position, fixing the implant using a metal non-biodegradable clip connected to the spacer, promoting bony in-growth and degradation of the biodegradable spacer, and removing the metal non-biodegradable clip in the case of an infection or other problem.
The subject invention, however, in other embodiments, need not achieve all these objectives and the claims hereof should not be limited to structures or methods capable of achieving these objectives.
Other objects, features and advantages will occur to those skilled in the art from the following description of a preferred embodiment and the accompanying drawings, in which:
Thus, in the case of infection, rejection, or some other problems requiring removal of the implant, all that need be removed are the two screws and the metal clip portion of the implant. Minimally invasive surgical techniques can be used. In the prior art, as explained in the Background section above, the titanium or stainless steel implant was secured in the space 18 by bony growth and was very difficult to remove. Minimally invasive surgical techniques could not be used.
One preferred version of the implant is shown in
With both fins intact, the implant is 27 mm long; with fin 24b cut off, the implant is 24 mm long; and with both fins 24a and 24b cut off, the implant is 21 mm long. In this way, one mold is effectively able to produce three different length implants. Other sizes are possible. Different width cages are possible.
Fins 24a and 24b as well as distal wall 36 of main section 22 are angled inwardly at 25° with respect to vertical resulting in an implant with a shorter bottom surface 40a and a longer top surface 40b,
In one example, the implant was 27 mm long at the top, 22 mm long at the bottom, 9 mm wide at the top, and 7 mm wide at the bottom. Fin connectors 32 were 2.1 by 6 by 1.2 mm. Slot 26 behind proximal face 50 was 1.2 mm wide.
Preferably, stainless steel or titanium 1 mm thick clip 28,
Although specific features of the invention are shown in some drawings and not in others, this is for convenience only as each feature may be combined with any or all of the other features in accordance with the invention. The words “including”, “comprising”, “having”, and “with” as used herein are to be interpreted broadly and comprehensively and are not limited to any physical interconnection. Moreover, any embodiments disclosed in the subject application are not to be taken as the only possible embodiments.
In addition, any amendment presented during the prosecution of the patent application for this patent is not a disclaimer of any claim element presented in the application as filed: those skilled in the art cannot reasonably be expected to draft a claim that would literally encompass all possible equivalents, many equivalents will be unforeseeable at the time of the amendment and are beyond a fair interpretation of what is to be surrendered (if anything), the rationale underlying the amendment may bear no more than a tangential relation to many equivalents, and/or there are many other reasons the applicant can not be expected to describe certain insubstantial substitutes for any claim element amended.
Other embodiments will occur to those skilled in the art and are within the following claims.
Anderson, David J., Kazanovicz, Andrew J.
| Patent | Priority | Assignee | Title |
| Patent | Priority | Assignee | Title |
| 7572291, | Mar 28 2006 | Warsaw Orthopedic, Inc | Osteochondral repair assembly including retracting spacer, kit and method |
| 7947073, | Apr 23 2002 | Boston Scientific Scimed, Inc. | Resorption-controllable medical implants |
| 8790410, | Jul 26 2012 | MWI Veterinary Supply Co. | Tibial tuberosity advancement implant |
| 20110319994, | |||
| 20120197410, | |||
| 20130190886, | |||
| 20140277545, |
| Executed on | Assignor | Assignee | Conveyance | Frame | Reel | Doc |
| Jun 02 2014 | MWI Veterinary Supply Co. | (assignment on the face of the patent) | / |
| Date | Maintenance Fee Events |
| Jan 16 2020 | M1551: Payment of Maintenance Fee, 4th Year, Large Entity. |
| Dec 13 2023 | M1552: Payment of Maintenance Fee, 8th Year, Large Entity. |
| Date | Maintenance Schedule |
| Jul 19 2019 | 4 years fee payment window open |
| Jan 19 2020 | 6 months grace period start (w surcharge) |
| Jul 19 2020 | patent expiry (for year 4) |
| Jul 19 2022 | 2 years to revive unintentionally abandoned end. (for year 4) |
| Jul 19 2023 | 8 years fee payment window open |
| Jan 19 2024 | 6 months grace period start (w surcharge) |
| Jul 19 2024 | patent expiry (for year 8) |
| Jul 19 2026 | 2 years to revive unintentionally abandoned end. (for year 8) |
| Jul 19 2027 | 12 years fee payment window open |
| Jan 19 2028 | 6 months grace period start (w surcharge) |
| Jul 19 2028 | patent expiry (for year 12) |
| Jul 19 2030 | 2 years to revive unintentionally abandoned end. (for year 12) |